Unique Biologic Properties of Recombinant AAV1 Transduction in Polarized Human Airway Epithelia
Open Access
- 6 October 2006
- journal article
- Published by Elsevier
- Vol. 281 (40), 29684-29692
- https://doi.org/10.1074/jbc.m604099200
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashionMolecular Therapy, 2006
- Intracellular trafficking of adeno-associated viral vectorsGene Therapy, 2005
- Dual Therapeutic Utility of Proteasome Modulating Agents for Pharmaco-gene Therapy of the Cystic Fibrosis AirwayMolecular Therapy, 2004
- Gene transfer into skeletal muscle using novel AAV serotypesThe Journal of Gene Medicine, 2004
- Distinct Classes of Proteasome-Modulating Agents Cooperatively Augment Recombinant Adeno-Associated Virus Type 2 and Type 5-Mediated Transduction from the Apical Surfaces of Human Airway EpitheliaJournal of Virology, 2004
- Second-Strand Genome Conversion of Adeno-Associated Virus Type 2 (AAV-2) and AAV-5 Is Not Rate Limiting following Apical Infection of Polarized Human Airway EpitheliaJournal of Virology, 2003
- Adeno-Associated Virus Type 2-Mediated Gene Transfer: Altered Endocytic Processing Enhances Transduction Efficiency in Murine FibroblastsJournal of Virology, 2001
- Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome DegradationJournal of Virology, 2001
- Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virusJournal of Clinical Investigation, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999